DNA: Revenue fell sharply but cash burn improved; autonomous labs and CRO services drive future growthQuartr·Aug 5 at 06:26 PMDNABW0.00%DNA-4.13%
Ginkgo Bioworks Q2 FY26 GAAP net loss widens to $57 million; revenue drops 48% to $20 millionPUBT·Aug 5 at 03:46 PMDNABW0.00%DNA-4.13%
DNA: Q2 2026 revenue dropped 48% year-over-year, with major autonomous lab contracts securedQuartr·Aug 5 at 03:13 PMDNA-4.13%DNABW0.00%
Ginkgo Bioworks expands autonomous lab network to Caltech, MIT, Maryland and NorthwesternPUBT·Aug 5 at 07:06 AMDNABW0.00%DNA-4.13%
Ginkgo Bioworks partners with Acies Bio to license Aspergillus niger strains for protein productionPUBT·Aug 3 at 08:04 AMDNA-4.13%DNABW0.00%
Ginkgo Bioworks to host Q2 2026 results presentation and Q&A sessionPUBT·Jul 30 at 03:35 PMDNA-4.13%DNABW0.00%
Ginkgo Datapoints, Tangible Scientific, and Inductive Bio Launch ADME-One™: a High-Throughput ADME Platform That Brings Pharmacokinetic Projection Earlier in Drug Discovery | DNA Stock NewsStockTitan·May 26 at 03:35 AMDNA-4.13%IBB-2.72%
GINKGO BIOWORKS HOLDINGS INC C/WTS 16/09/2026 (TO PUR COM) | 10-Q: FY2026 Q1 Revenue: USD 19.47 MEarnings Watch·May 7 at 10:42 PMDNABW0.00%
GINKGO BIOWORKS HOLDINGS INC C/WTS 16/09/2026 (TO PUR COM) | 8-K: FY2026 Q1 Revenue: USD 19.47 MEarnings Watch·May 7 at 03:22 PMDNABW0.00%
08:01 ETGinkgo Bioworks Announces Date of First Quarter 2026 Results Presentationprnewswire·Apr 30 at 07:02 AMDNABW0.00%DNA-4.13%
FDA shares guide on genome editing best practicesPharmaceutical Technology·Apr 15 at 10:03 AMNTLA-1.83%DNABW0.00%
Ginkgo Bioworks Officer Sold Shares Worth Over $802KTradingView·Apr 13 at 04:10 PMDNA-4.13%DNABW0.00%
